| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.899 | 0.003 | 0.899 | 5 Hydroxytryptamine antagonist | 0.837 0.003 DBMET03491 0.724 0.004 DBMET03492 | ||
| 0.89 | 0.003 | 0.89 | 5 Hydroxytryptamine 2 antagonist | 0.817 0.003 DBMET03491 0.684 0.004 DBMET03492 | ||
| 0.88 | 0.003 | 0.88 | Dopamine D2 antagonist | 0.742 0.004 DBMET03491 0.664 0.004 DBMET03492 | ||
| 0.872 | 0.003 | 0.872 | Dopamine antagonist | 0.779 0.003 DBMET03491 0.661 0.004 DBMET03492 | ||
| 0.854 | 0.002 | 0.854 | 5 Hydroxytryptamine 2A antagonist | 0.749 0.003 DBMET03491 0.638 0.004 DBMET03492 | ||
| 0.812 | 0.002 | 0.812 | Dopamine D3 antagonist | 0.744 0.002 DBMET03491 0.669 0.003 DBMET03492 | ||
| 0.737 | 0.003 | 0.737 | Dopamine D2 agonist | 0.53 0.004 DBMET03491 0.594 0.003 DBMET03492 | ||
| 0.73 | 0.003 | 0.73 | Dopamine agonist | 0.583 0.004 DBMET03491 0.625 0.004 DBMET03492 | ||
| 0.642 | 0.004 | 0.642 | 5 Hydroxytryptamine 2B antagonist | 0.504 0.005 DBMET03491 0.372 0.01 DBMET03492 | ||
| 0.568 | 0.005 | 0.568 | Alpha adrenoreceptor antagonist | 0.39 0.01 DBMET03491 0.368 0.011 DBMET03492 | ||
| 0.527 | 0.004 | 0.527 | 5 Hydroxytryptamine 2C antagonist | 0.439 0.005 DBMET03491 0.298 0.009 DBMET03492 | ||
| 0.525 | 0.004 | 0.525 | Dopamine D4 antagonist | 0.286 0.008 DBMET03491 0.265 0.008 DBMET03492 | ||
| 0.498 | 0.003 | 0.498 | Dopamine D3 agonist | 0.373 0.003 DBMET03491 0.419 0.003 DBMET03492 | ||
| 0.497 | 0.016 | 0.497 | HERG channel blocker | 0.48 0.017 DBMET03491 0.478 0.017 DBMET03492 | ||
| 0.485 | 0.005 | 0.485 | 5 Hydroxytryptamine 1 antagonist | 0.373 0.007 DBMET03491 0.27 0.012 DBMET03492 | ||
| 0.482 | 0.004 | 0.482 | Alpha 2 adrenoreceptor antagonist | 0.308 0.008 DBMET03491 0.237 0.013 DBMET03492 | ||
| 0.451 | 0.003 | 0.451 | 5 Hydroxytryptamine 5A antagonist | 0.311 0.004 DBMET03491 0.24 0.004 DBMET03492 | ||
| 0.457 | 0.019 | 0.457 | Potassium channel (Voltage-sensitive) blocker | 0.453 0.019 DBMET03491 0.441 0.021 DBMET03492 | ||
| 0.436 | 0.005 | 0.436 | Alpha 1a adrenoreceptor antagonist | 0.323 0.008 DBMET03491 0.31 0.009 DBMET03492 | ||
| 0.423 | 0.005 | 0.423 | 5 Hydroxytryptamine 1A antagonist | 0.279 0.01 DBMET03491 0.237 0.012 DBMET03492 | ||
| 0.473 | 0.057 | 0.488 | Analgesic | 0.488 0.053 DBMET03491 0.403 0.083 DBMET03492 | DBMET03491 | |
| 0.412 | 0.006 | 0.412 | Alpha 1 adrenoreceptor antagonist | 0.31 0.01 DBMET03491 0.305 0.01 DBMET03492 | ||
| 0.401 | 0.004 | 0.401 | Neuropeptide Y antagonist | 0.395 0.004 DBMET03491 0.4 0.004 DBMET03492 | ||
| 0.416 | 0.019 | 0.416 | Sigma receptor agonist | 0.375 0.026 DBMET03491 0.363 0.028 DBMET03492 | ||
| 0.4 | 0.005 | 0.4 | Alpha 2a adrenoreceptor antagonist | 0.334 0.005 DBMET03491 0.255 0.009 DBMET03492 | ||
| 0.379 | 0.003 | 0.379 | 5 Hydroxytryptamine 5 antagonist | 0.283 0.004 DBMET03491 0.213 0.005 DBMET03492 | ||
| 0.368 | 0.004 | 0.368 | Dopamine D4 agonist | 0.347 0.004 DBMET03491 0.353 0.004 DBMET03492 | ||
| 0.358 | 0.005 | 0.358 | 5 Hydroxytryptamine 1 agonist | 0.273 0.008 DBMET03491 0.264 0.008 DBMET03492 | ||
| 0.352 | 0.005 | 0.352 | 5 Hydroxytryptamine 1A agonist | 0.293 0.006 DBMET03491 0.288 0.006 DBMET03492 | ||
| 0.353 | 0.006 | 0.353 | Alpha 1b adrenoreceptor antagonist | 0.274 0.009 DBMET03491 0.236 0.011 DBMET03492 | ||
| 0.351 | 0.005 | 0.351 | Dopamine D1 antagonist | 0.19 0.011 DBMET03491 0.154 0.014 DBMET03492 | ||
| 0.351 | 0.01 | 0.351 | 5 Hydroxytryptamine 1E antagonist | 0.341 0.012 DBMET03491 0.327 0.016 DBMET03492 | ||
| 0.345 | 0.005 | 0.345 | Alpha 2c adrenoreceptor antagonist | 0.297 0.007 DBMET03491 0.217 0.015 DBMET03492 | ||
| 0.337 | 0.005 | 0.337 | Alpha 1d adrenoreceptor antagonist | 0.236 0.007 DBMET03491 0.231 0.008 DBMET03492 | ||
| 0.325 | 0.004 | 0.331 | 5 Hydroxytryptamine 1B antagonist | 0.331 0.004 DBMET03491 0.179 0.01 DBMET03492 | DBMET03491 | |
| 0.325 | 0.005 | 0.335 | 5 Hydroxytryptamine 7 antagonist | 0.335 0.005 DBMET03491 0.32 0.005 DBMET03492 | DBMET03491 | |
| 0.324 | 0.012 | 0.324 | Neuropeptide Y2 antagonist | 0.299 0.019 DBMET03491 0.323 0.012 DBMET03492 | ||
| 0.298 | 0.009 | 0.298 | Alpha 2b adrenoreceptor antagonist | 0.246 0.015 DBMET03491 0.194 0.025 DBMET03492 | ||
| 0.301 | 0.013 | 0.301 | Antiadrenergic | 0.267 0.016 DBMET03491 0.249 0.017 DBMET03492 | ||
| 0.297 | 0.013 | 0.297 | Adrenaline antagonist | 0.262 0.016 DBMET03491 0.245 0.017 DBMET03492 | ||
| 0.286 | 0.005 | 0.348 | Neuropeptide Y1 antagonist | 0.348 0.004 DBMET03491 0.318 0.004 DBMET03492 | DBMET03491 | |
| 0.287 | 0.009 | 0.287 | 5 Hydroxytryptamine agonist | 0.239 0.011 DBMET03491 0.234 0.012 DBMET03492 | ||
| 0.304 | 0.028 | 0.304 | MAP-kinase-activated kinase 5 inhibitor | 0.164 0.159 DBMET03491 0.173 0.144 DBMET03492 | ||
| 0.278 | 0.019 | 0.313 | Acetylcholine M1 receptor antagonist | 0.313 0.012 DBMET03491 0.243 0.027 DBMET03492 | DBMET03491 | |
| 0.296 | 0.048 | 0.329 | Potassium channel blocker | 0.329 0.038 DBMET03491 0.276 0.055 DBMET03492 | DBMET03491 | |
| 0.228 | 0.005 | 0.244 | 5 Hydroxytryptamine 1D antagonist | 0.244 0.005 DBMET03491 0.145 0.013 DBMET03492 | DBMET03491 | |
| 0.23 | 0.009 | 0.256 | 5 Hydroxytryptamine uptake inhibitor | 0.256 0.008 DBMET03491 0.155 0.015 DBMET03492 | DBMET03491 | |
| 0.27 | 0.057 | 0.287 | Gastrin inhibitor | 0.287 0.043 DBMET03491 0.273 0.054 DBMET03492 | DBMET03491 | |
| 0.215 | 0.004 | 0.354 | CC chemokine 3 receptor antagonist | 0.354 0.003 DBMET03491 0.178 0.005 DBMET03492 | DBMET03491 | |
| 0.222 | 0.019 | 0.222 | Acetylcholine muscarinic antagonist | 0.211 0.022 DBMET03491 0.142 0.049 DBMET03492 | ||
| 0.2 | 0.005 | 0.2 | Melanin-concentrating hormone receptor 1 antagonist | 0.13 0.008 DBMET03491 0.066 0.026 DBMET03492 | ||
| 0.205 | 0.017 | 0.229 | Chemokine receptor antagonist | 0.226 0.014 DBMET03491 0.229 0.014 DBMET03492 | DBMET03492 | |
| 0.299 | 0.117 | 0.299 | Antiobesity | 0.269 0.14 DBMET03491 0.281 0.131 DBMET03492 | ||
| 0.201 | 0.03 | 0.201 | Acetylcholine antagonist | 0.196 0.032 DBMET03491 0.124 0.067 DBMET03492 | ||
| 0.202 | 0.032 | 0.202 | Cholinergic antagonist | 0.197 0.033 DBMET03491 0.124 0.07 DBMET03492 | ||
| 0.173 | 0.007 | 0.296 | Amidase inhibitor | 0.249 0.005 DBMET03491 0.296 0.004 DBMET03492 | DBMET03492 | |
| 0.151 | 0.003 | 0.151 | Dopamine autoreceptor agonist | 0.112 0.004 DBMET03491 0.096 0.004 DBMET03492 | ||
| 0.153 | 0.009 | 0.169 | 5 Hydroxytryptamine 3 antagonist | 0.169 0.008 DBMET03491 0.144 0.01 DBMET03492 | DBMET03491 | |
| 0.147 | 0.005 | 0.147 | Oleamide hydrolase inhibitor | 0.143 0.005 DBMET03491 0.115 0.007 DBMET03492 | ||
| 0.153 | 0.016 | 0.255 | Alpha adrenoreceptor agonist | 0.255 0.005 DBMET03491 0.177 0.011 DBMET03492 | DBMET03491 | |
| 0.141 | 0.012 | 0.141 | Sigma receptor antagonist | 0.118 0.014 DBMET03491 0.115 0.014 DBMET03492 | ||
| 0.138 | 0.009 | 0.138 | Acetylcholine M5 receptor antagonist | 0.112 0.014 DBMET03491 0.108 0.015 DBMET03492 | ||
| 0.183 | 0.058 | 0.183 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.134 | 0.012 | 0.134 | Dopamine uptake inhibitor | 0.134 0.012 DBMET03491 0.088 0.022 DBMET03492 | ||
| 0.132 | 0.022 | 0.166 | CC chemokine receptor antagonist | 0.166 0.015 DBMET03491 0.154 0.017 DBMET03492 | DBMET03491 | |
| 0.189 | 0.083 | 0.19 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.082 DBMET03491 0.179 0.109 DBMET03492 | DBMET03491 | |
| 0.113 | 0.011 | 0.186 | Alpha 2 adrenoreceptor agonist | 0.186 0.005 DBMET03491 0.143 0.007 DBMET03492 | DBMET03491 | |
| 0.164 | 0.068 | 0.164 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.109 | 0.013 | 0.109 | Calcium channel T-type blocker | 0.065 0.032 DBMET03491 0.052 0.051 DBMET03492 | ||
| 0.102 | 0.013 | 0.12 | CC chemokine 2 receptor antagonist | 0.12 0.009 DBMET03491 0.07 0.024 DBMET03492 | DBMET03491 | |
| 0.106 | 0.02 | 0.106 | Acetylcholine M2 receptor antagonist | 0.083 0.028 DBMET03491 | ||
| 0.131 | 0.047 | 0.191 | 5 Hydroxytryptamine 3A agonist | 0.174 0.024 DBMET03491 0.191 0.018 DBMET03492 | DBMET03492 | |
| 0.1 | 0.017 | 0.108 | Alpha 1 adrenoreceptor agonist | 0.108 0.015 DBMET03491 0.071 0.027 DBMET03492 | DBMET03491 | |
| 0.105 | 0.022 | 0.105 | CXC chemokine receptor antagonist | 0.085 0.034 DBMET03491 0.104 0.022 DBMET03492 | ||
| 0.102 | 0.02 | 0.102 | Ca(v)3.1 blocker | 0.082 0.055 DBMET03491 0.078 0.067 DBMET03492 | ||
| 0.155 | 0.073 | 0.155 | Cholinergic | |||
| 0.122 | 0.042 | 0.158 | Antihistaminic | 0.158 0.03 DBMET03491 0.095 0.059 DBMET03492 | DBMET03491 | |
| 0.117 | 0.037 | 0.165 | NMDA receptor antagonist | 0.109 0.042 DBMET03491 0.165 0.02 DBMET03492 | DBMET03492 | |
| 0.097 | 0.019 | 0.111 | Adrenaline uptake inhibitor | 0.111 0.016 DBMET03491 0.066 0.038 DBMET03492 | DBMET03491 | |
| 0.116 | 0.04 | 0.153 | Histamine antagonist | 0.153 0.029 DBMET03491 0.088 0.056 DBMET03492 | DBMET03491 | |
| 0.104 | 0.03 | 0.104 | 5 Hydroxytryptamine 1F antagonist | 0.101 0.031 DBMET03491 | ||
| 0.12 | 0.049 | 0.12 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.151 | 0.083 | 0.151 | Polo-like kinase-3 inhibitor | |||
| 0.105 | 0.039 | 0.105 | Histamine H1 receptor antagonist | 0.097 0.043 DBMET03491 0.089 0.049 DBMET03492 | ||
| 0.17 | 0.104 | 0.17 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.15 0.128 DBMET03491 0.151 0.127 DBMET03492 | ||
| 0.091 | 0.026 | 0.102 | Purinergic P2 antagonist | 0.102 0.021 DBMET03491 0.097 0.023 DBMET03492 | DBMET03491 | |
| 0.077 | 0.014 | 0.077 | Prolactin release inhibitor | |||
| 0.086 | 0.023 | 0.089 | 5 Hydroxytryptamine 2A agonist | 0.069 0.038 DBMET03491 0.089 0.02 DBMET03492 | DBMET03492 | |
| 0.17 | 0.107 | 0.299 | Anticonvulsant | 0.299 0.041 DBMET03491 0.295 0.042 DBMET03492 | DBMET03491 | |
| 0.069 | 0.006 | 0.069 | Sigma 2 receptor antagonist | 0.049 0.01 DBMET03491 0.04 0.013 DBMET03492 | ||
| 0.076 | 0.014 | 0.079 | 5 Hydroxytryptamine 4 antagonist | 0.079 0.013 DBMET03491 0.074 0.015 DBMET03492 | DBMET03491 | |
| 0.074 | 0.015 | 0.074 | Neurokinin 2 antagonist | 0.043 0.027 DBMET03491 0.04 0.03 DBMET03492 | ||
| 0.127 | 0.072 | 0.127 | Acetylcholinesterase inhibitor | |||
| 0.08 | 0.026 | 0.13 | Acetylcholine M3 receptor antagonist | 0.13 0.013 DBMET03491 0.064 0.037 DBMET03492 | DBMET03491 | |
| 0.285 | 0.234 | 0.336 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.336 0.167 DBMET03491 0.286 0.233 DBMET03492 | DBMET03491 | |
| 0.064 | 0.016 | 0.07 | Histamine H4 receptor antagonist | 0.067 0.014 DBMET03491 0.07 0.012 DBMET03492 | DBMET03492 | |
| 0.101 | 0.054 | 0.101 | Prolactin inhibitor | |||
| 0.078 | 0.033 | 0.08 | 5 Hydroxytryptamine 3A antagonist | 0.08 0.031 DBMET03491 0.074 0.037 DBMET03492 | DBMET03491 | |
| 0.09 | 0.046 | 0.09 | Acetylcholine nicotinic agonist | 0.087 0.048 DBMET03491 | ||
| 0.139 | 0.097 | 0.139 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.081 | 0.039 | 0.109 | Cannabinoid receptor antagonist | 0.109 0.025 DBMET03491 0.066 0.054 DBMET03492 | DBMET03491 | |
| 0.067 | 0.026 | 0.067 | Acetyl-CoA transferase inhibitor | |||
| 0.077 | 0.037 | 0.077 | Cannabinoid receptor agonist | 0.069 0.042 DBMET03491 0.072 0.04 DBMET03492 | ||
| 0.051 | 0.014 | 0.053 | Purinergic P2X7 antagonist | 0.053 0.013 DBMET03491 0.052 0.013 DBMET03492 | DBMET03491 | |
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | 0.07 0.062 DBMET03491 0.076 0.053 DBMET03492 | ||
| 0.043 | 0.008 | 0.053 | Epoxide hydrolase 2 inhibitor | 0.053 0.005 DBMET03491 0.046 0.007 DBMET03492 | DBMET03491 | |
| 0.059 | 0.024 | 0.063 | Purinergic P2X antagonist | 0.061 0.023 DBMET03491 0.063 0.021 DBMET03492 | DBMET03492 | |
| 0.042 | 0.008 | 0.163 | CC chemokine 1 receptor antagonist | 0.141 0.004 DBMET03491 0.163 0.004 DBMET03492 | DBMET03492 | |
| 0.084 | 0.052 | 0.085 | Opioid kappa receptor antagonist | 0.08 0.058 DBMET03491 0.085 0.052 DBMET03492 | DBMET03492 | |
| 0.076 | 0.046 | 0.103 | Epoxide hydrolase inhibitor | 0.103 0.023 DBMET03491 0.09 0.033 DBMET03492 | DBMET03491 | |
| 0.042 | 0.012 | 0.042 | Sigma 1 receptor antagonist | 0.036 0.014 DBMET03491 0.033 0.015 DBMET03492 | ||
| 0.055 | 0.028 | 0.055 | Antiviral (Hepatitis D) | |||
| 0.058 | 0.031 | 0.058 | Neuropeptide Y5 antagonist | |||
| 0.065 | 0.039 | 0.106 | Cannabinoid CB1 receptor agonist | 0.088 0.024 DBMET03491 0.106 0.018 DBMET03492 | DBMET03492 | |
| 0.056 | 0.03 | 0.061 | Chemokine receptor agonist | 0.043 0.041 DBMET03491 0.061 0.026 DBMET03492 | DBMET03492 | |
| 0.039 | 0.014 | 0.041 | CXC chemokine 3 receptor antagonist | 0.041 0.013 DBMET03491 0.036 0.016 DBMET03492 | DBMET03491 | |
| 0.052 | 0.032 | 0.052 | Neurokinin antagonist | |||
| 0.044 | 0.024 | 0.044 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.143 | 0.123 | 0.158 | Psychostimulant | 0.158 0.109 DBMET03491 0.158 0.11 DBMET03492 | DBMET03492 | |
| 0.111 | 0.092 | 0.111 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.042 | 0.024 | 0.042 | Substance P antagonist | |||
| 0.142 | 0.123 | 0.184 | Phospholipase C inhibitor | 0.184 0.056 DBMET03492 | DBMET03492 | |
| 0.043 | 0.025 | 0.056 | Nicotinic acid receptor 1 agonist | 0.056 0.018 DBMET03491 0.05 0.02 DBMET03492 | DBMET03491 | |
| 0.061 | 0.044 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.05 DBMET03491 0.071 0.027 DBMET03492 | DBMET03492 | |
| 0.055 | 0.04 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.038 DBMET03491 0.052 0.048 DBMET03492 | DBMET03491 | |
| 0.176 | 0.16 | 0.176 | DNA synthesis inhibitor | |||
| 0.051 | 0.036 | 0.051 | Cannabinoid CB2 receptor antagonist | |||
| 0.039 | 0.024 | 0.041 | Integrin alpha1beta1 antagonist | 0.04 0.021 DBMET03491 0.041 0.02 DBMET03492 | DBMET03492 | |
| 0.034 | 0.019 | 0.034 | Acetylcholine M4 receptor agonist | |||
| 0.052 | 0.037 | 0.057 | Histamine agonist | 0.047 0.045 DBMET03491 0.057 0.03 DBMET03492 | DBMET03492 | |
| 0.058 | 0.044 | 0.058 | Ca(v)3.2 blocker | 0.055 0.052 DBMET03491 | ||
| 0.048 | 0.035 | 0.051 | CC chemokine receptor 2B antagonist | 0.047 0.037 DBMET03491 0.051 0.03 DBMET03492 | DBMET03492 | |
| 0.021 | 0.01 | 0.021 | Apolipoprotein B-100 inhibitor | |||
| 0.025 | 0.015 | 0.025 | 5 Hydroxytryptamine 4 agonist | 0.025 0.016 DBMET03491 0.024 0.017 DBMET03492 | ||
| 0.044 | 0.037 | 0.044 | Glycine transporter inhibitor | 0.042 0.038 DBMET03491 | ||
| 0.096 | 0.09 | 0.096 | Calcium channel (voltage-sensitive) blocker | |||
| 0.067 | 0.061 | 0.067 | Acetylcholine M4 receptor antagonist | |||
| 0.046 | 0.041 | 0.054 | CC chemokine 5 receptor antagonist | 0.054 0.031 DBMET03491 0.046 0.043 DBMET03492 | DBMET03491 | |
| 0.043 | 0.039 | 0.044 | Dopamine transporter inhibitor | 0.044 0.038 DBMET03491 | DBMET03491 | |
| 0.09 | 0.086 | 0.098 | EphA2 antagonist | 0.095 0.081 DBMET03491 0.098 0.078 DBMET03492 | DBMET03492 | |
| 0.076 | 0.072 | 0.076 | Acetylcholine agonist | |||
| 0.051 | 0.048 | 0.051 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.03 | 0.029 | 0.03 | Nociceptin (N/OFQ) receptor antagonist | 0.03 0.028 DBMET03492 | ||
| 0.071 | 0.071 | 0.117 | Adrenaline agonist | 0.117 0.027 DBMET03491 0.101 0.036 DBMET03492 | DBMET03491 | |
| 0.028 | 0.029 | 0.033 | CXC chemokine receptor agonist | 0.033 0.025 DBMET03492 | DBMET03492 | |
| 0.053 | 0.055 | 0.072 | Cannabinoid CB1 receptor antagonist | 0.072 0.033 DBMET03491 | DBMET03491 | |
| 0.188 | 0.191 | 0.222 | Vasodilator, peripheral | 0.222 0.152 DBMET03491 | DBMET03491 | |
| 0.033 | 0.037 | 0.034 | Delayed rectifier potassium channel blocker | 0.034 0.033 DBMET03491 | DBMET03491 | |
| 0.073 | 0.08 | 0.085 | Histamine H2 receptor antagonist | 0.085 0.054 DBMET03491 | DBMET03491 | |
| 0.073 | 0.08 | 0.077 | Opioid antagonist | 0.077 0.073 DBMET03492 | DBMET03492 | |
| 0.068 | 0.075 | 0.086 | Cell adhesion molecule inhibitor | 0.086 0.046 DBMET03491 | DBMET03491 | |
| 0.023 | 0.032 | 0.034 | Peptide deformylase inhibitor | 0.034 0.018 DBMET03491 | DBMET03491 | |
| 0.025 | 0.035 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.034 0.016 DBMET03491 0.029 0.024 DBMET03492 | DBMET03491 | |
| 0.128 | 0.14 | 0.165 | Anesthetic general | 0.165 0.098 DBMET03492 | DBMET03492 | |
| 0.024 | 0.049 | 0.031 | DNA topoisomerase IV inhibitor | 0.031 0.018 DBMET03491 | DBMET03491 | |
| 0.231 | 0.257 | 0.283 | 5 Hydroxytryptamine release inhibitor | 0.283 0.185 DBMET03492 | DBMET03492 | |
| 0.028 | 0.071 | 0.039 | Glucose-6-phosphate dehydrogenase inhibitor | 0.039 0.023 DBMET03492 | DBMET03492 | |
| 0.131 | 0.184 | 0.196 | Spasmolytic | 0.196 0.123 DBMET03491 | DBMET03491 | |
| 0.034 | 0.087 | 0.044 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.04 DBMET03491 | DBMET03491 | |
| 0.05 | 0.109 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.05 DBMET03492 | DBMET03492 | |
| 0.093 | 0.155 | 0.119 | Anticoagulant | 0.119 0.113 DBMET03492 | DBMET03492 | |
| 0.029 | 0.094 | 0.05 | Nicotinic neuronal receptor agonist | 0.05 0.045 DBMET03491 | DBMET03491 | |
| 0.021 | 0.087 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.029 DBMET03492 | DBMET03492 | |
| 0.073 | 0.145 | 0.09 | Glutamate (mGluR7) agonist | 0.09 0.084 DBMET03491 | DBMET03491 | |
| 0.028 | 0.105 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.037 DBMET03491 | DBMET03491 | |
| 0.106 | 0.191 | 0.17 | Antipruritic | 0.155 0.089 DBMET03491 0.17 0.074 DBMET03492 | DBMET03492 | |
| 0.037 | 0.126 | 0.071 | DNA gyrase inhibitor | 0.071 0.035 DBMET03491 | DBMET03491 | |
| 0.069 | 0.16 | 0.102 | mTOR complex 1 inhibitor | 0.102 0.057 DBMET03491 | DBMET03491 | |
| 0.162 | 0.257 | 0.343 | Toll-Like receptor 7 agonist | 0.343 0.086 DBMET03492 | DBMET03492 | |
| 0.154 | 0.27 | 0.336 | Toll-Like receptor agonist | 0.336 0.089 DBMET03492 | DBMET03492 | |
| 0.105 | 0.225 | 0.211 | Tumour necrosis factor alpha release inhibitor | 0.211 0.099 DBMET03492 | DBMET03492 | |
| 0.035 | 0.202 | 0.092 | Somatostatin 1 agonist | 0.092 0.04 DBMET03492 | DBMET03492 | |
| 0.065 | 0.375 | 0.152 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.152 0.142 DBMET03492 | DBMET03492 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |